It is known that BGN modulates several pathways that are of relevance for bladder cancer progression such as the Wnt/β -catenin pathway, the TGFβ signaling, inflammatory signaling through TLR receptors and the P2X7 receptor. This evidence concerns the gene BGN and urinary bladder carcinoma.